News related to Abilify (Aripiprazole) and/or conditions it is approved for
Results announced from the QUALIFY study in schizophrenia
Source: Clinical Trials / Drug Trials News From Medical News Today [2015.03.31]
Otsuka Pharmaceutical Europe Ltd. presented the results of the QUALIFY* study, which showed the superiority of Abilify Maintena compared to paliperidone palmitate when using the Heinrichs-Carpenter...
Study shows INVEGA SUSTENNA effective six months longer than common oral antipsychotics in treatment of schizophrenia
Source: Schizophrenia News From Medical News Today [2015.04.17]
A study published in The Journal of Clinical Psychiatry shows that long-acting INVEGA SUSTENNA® (paliperidone palmitate) was effective six months longer than commonly prescribed oral...
Discovery of communication link between brain areas implicated in schizophrenia
Source: Schizophrenia News From Medical News Today [2015.04.10]
Disruptions are in an inhibitory brain circuit between the thalamus and prefrontal cortexThe CSHL team induced PV interneurons of the medial prefrontal cortex (mPFC) to produce a red...
TSRI scientists find molecular trigger of schizophrenia-like behaviors and brain changes
Source: Autism News From Medical News Today [2015.04.09]
Scientists at The Scripps Research Institute (TSRI) have identified a molecule in the brain that triggers schizophrenia-like behaviors, brain changes and global gene expression in an animal model.
Exercise Might Boost Mental Function in People With Schizophrenia
Source: MedicineNet Exercise and Activity Specialty [2015.04.06]
Title: Exercise Might Boost Mental Function in People With Schizophrenia
Category: Health News
Created: 4/3/2015 12:00:00 AM
Last Editorial Review: 4/6/2015 12:00:00 AM
New post-hoc analyses extend understanding of the efficacy and safety of lurasidone in the treatment of schizophrenia
Source: Clinical Trials / Drug Trials News From Medical News Today [2015.04.02]
Takeda Pharmaceuticals International GmbH and Sunovion Pharmaceuticals Inc. have announced the results from three post-hoc analyses evaluating the efficacy and safety of Latuda® (lurasidone) in...
New study found three-month paliperidone palmitate significantly delayed time to relapse in patients with schizophrenia
Source: Clinical Trials / Drug Trials News From Medical News Today [2015.04.01]
Three-month paliperidone palmitate, an investigational atypical antipsychotic, significantly delayed time to relapse compared to placebo in patients with schizophrenia, according to a new Phase 3...
Finger lengths may indicate risk of schizophrenia in males
Source: Endocrinology News From Medical News Today [2015.03.19]
Research suggests that the ratio of the lengths of the index finger and the ring finger in males may be predictive of a variety of disorders related to disturbed hormonal balance.
Rat brains point to lead's role in schizophrenia
Source: Schizophrenia News From Medical News Today [2015.03.16]
A study of the brains of rats exposed to lead has uncovered striking similarities with what is known about the brains of human schizophrenia patients, adding compelling evidence that lead is a factor...
Abnormal brain rhythms tied to problems with thinking in schizophrenia
Source: Schizophrenia News From Medical News Today [2015.03.09]
Study of unique mouse model shows cognitive deficits may be reversibleBy studying specially bred mice with specific developmental and cognitive traits resembling those seen in schizophrenia, UC...
Medicare and patients with schizophrenia could save $150 million on Part D plans
Source: Health Insurance / Medical Insurance News From Medical News Today [2015.03.02]
Using an "intelligent," rather than random, method for assigning people with schizophrenia to Medicare Part D prescription drug coverage plans could save Medicare and patients a combined $150...
An evolutionary approach reveals new clues toward understanding the roots of schizophrenia
Source: Bipolar News From Medical News Today [2015.02.26]
Is mental illness simply the evolutionary toll humans have to pay in return for our unique and superior cognitive abilities when compared to all other species?
Study Finds Need for Improved Schizophrenia Care
Source: MedicineNet olanzapine Specialty [2014.12.04]
Title: Study Finds Need for Improved Schizophrenia Care
Category: Health News
Created: 12/4/2014 12:00:00 AM
Last Editorial Review: 12/4/2014 12:00:00 AM
Schizophrenia Pictures Slideshow: Types, Causes, Symptoms, and Treatment
Source: MedicineNet aripiprazole Specialty [2014.10.14]
Title: Schizophrenia Pictures Slideshow: Types, Causes, Symptoms, and Treatment
Created: 9/27/2010 9:31:00 AM
Last Editorial Review: 10/14/2014 12:00:00 AM
Source: MedicineNet Electroconvulsive Therapy Specialty [2014.04.11]
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 4/11/2014 12:00:00 AM
Schizophrenia and Electroconvulsive Therapy (ECT)
Source: MedicineNet Electroconvulsive Therapy Specialty [2012.02.14]
Title: Schizophrenia and Electroconvulsive Therapy (ECT)
Category: WebMD Second Source
Created: 11/3/2005 12:00:00 AM
Last Editorial Review: 2/14/2012 12:00:00 AM
Zyprexa in schizophrenia shown to prevent brain loss
Source: The Doctors Lounge - Psychiatry
Zyprexa (olanzapine) was found to decrease brain loss in schizophrenia patients according to the Archives of General Psychiatry.
Mighty microexons take center stage in shaping of the brain
Source: Autism News From Medical News Today [2015.04.05]
Complex brain disorders, such as autism or schizophrenia, still puzzle scientists because their causes lie hidden in early events of brain development, which are still poorly understood.
With kids' antipsychotic treatment on the rise, study looks at prescriber decision-making
Source: Bipolar News From Medical News Today [2015.03.04]
More kids nationwide are taking medications designed to treat such mental illnesses as schizophrenia and bipolar disorder, and pediatricians and psychiatrists at the University of Vermont want to...
Coral snake venom reveals a unique route to lethality
Source: Epilepsy News From Medical News Today [2015.02.11]
Venom's toxins will be a powerful tool for studying epilepsy, schizophrenia and chronic painFast Facts: The reason for the lethality of venom from the rare, reclusive Costa Rican coral...